Arbitrator hands down ruling in favor of former Johnson & Johnson executive seeking return of assets of HIV testing company he sold to J&J.NEWARK, N.J.--(BUSINESS WIRE)--July 16, 1996--An arbitrator arbitrator n. one who conducts an arbitration, and serves as a judge who conducts a "mini-trial," somewhat less formally than a court trial. In most cases the arbitraror is an attorney, either alone or as part of a panel. has handed down a ruling in favor of a former Johnson & Johnson executive in a case in which the executive is seeking the return of all of the assets of the HIV testing HIV test Various tests have been used to detect HIV and production of antibodies thereto; some HTs shown below are no longer actively used, but are listed for completeness and context. See HIV, Immunoblot. company he sold to Johnson & Johnson in 1993. In a ruling handed down yesterday, the arbitrator for the American Arbitration Association The American Arbitration Association (AAA) is a private enterprise in the business of arbitration, and one of several arbitration organizations that administers arbitration proceedings. The AAA also administers mediation and other forms of alternative dispute resolution. , John J. Gibbons Famous people named Gibbons include:
Millenson is the former president and chief executive officer of J&J's Direct Access Diagnostics subsidiary. He served in that role until early 1995 when, his attorneys say, his employment was abruptly terminated by Johnson & Johnson. J. Alan Galbraith, an attorney with the Washington, D.C. law firm of Williams & Connolly, said that under terms of the employment agreement Millenson signed with J&J in 1993 when he sold his Confide(TM) HIV Testing Service to J&J, Millenson, if terminated without cause, is entitled to, among other things, the return of all J&J assets relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the Confide service. Arbitrator Gibbons has asked the parties in the case to make submissions regarding this remedy within the next seven days. In May, Confide was approved for marketing by the Food & Drug Administration. Analysts have estimated Confide's potential international annual market to approach $1 billion, Millenson's attorneys said. Millenson's attorney Galbraith said that if Millenson gets the assets of his company back, "he'll have the company market Confide aggressively on a national basis so that the American people An American people may be:
CONTACT: J. Alan Galbraith Law Offices/Williams & Connolly 202/434-5023 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion